{"id":30944,"date":"2025-08-07T08:52:36","date_gmt":"2025-08-07T08:52:36","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/cz\/?page_id=30944"},"modified":"2025-08-07T08:52:56","modified_gmt":"2025-08-07T08:52:56","slug":"nefinancni-reporting","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/cz\/nefinancni-reporting","title":{"rendered":"Nefinancni reporting"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"30944\" class=\"elementor elementor-30944\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6d9f2173 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6d9f2173\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-68613d92\" data-id=\"68613d92\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-4217e500 elementor-widget elementor-widget-text-editor\" data-id=\"4217e500\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Estado de Informaci\u00f3n No Financiera &#8211; EINF, ve \u0161pan\u011bl\u0161tin\u011b)<\/p><p>Neuraxpharm Pharmaceuticals S.L.U. (d\u0159\u00edve Laboratorios Lesvi S.L.U.) p\u0159ipravuje ka\u017ed\u00fd rok v souladu se z\u00e1konem 11\/2018 t\u00fdkaj\u00edc\u00edm se nefinan\u010dn\u00edho reportingu a diverzity sv\u016fj nefinan\u010dn\u00ed reporting, kter\u00fd se \u0159\u00edd\u00ed doporu\u010den\u00edmi a \u00fadaji, je\u017e v\u00fd\u0161e zm\u00edn\u011bn\u00fd z\u00e1kon 11\/2018 stanovuje.<\/p><p>Sou\u010d\u00e1st\u00ed tohoto reportu jsou informace t\u00fdkaj\u00edc\u00ed se \u017eivotn\u00edho prost\u0159ed\u00ed, soci\u00e1ln\u00edch a person\u00e1ln\u00edch ot\u00e1zek, lidsk\u00fdch pr\u00e1v, boje proti korupci a podpl\u00e1cen\u00ed a vlivu organizace na spole\u010dnost. U ka\u017ed\u00e9 takov\u00e9 ot\u00e1zky popisujeme na\u0161e z\u00e1sady a proveden\u00e9 kroky, stejn\u011b tak jako vyhodnocen\u00e1 rizika, kter\u00e1 vych\u00e1zej\u00ed z aktivity na\u0161\u00ed spole\u010dnosti. Report je p\u0159ipravov\u00e1n v souladu se z\u00e1sadami srovnatelnosti, spolehlivosti, v\u00fdznamnosti a relevantnosti, je\u017e v\u00fd\u0161e zm\u00edn\u011bn\u00fd z\u00e1kon 11\/2018 stanovuje.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-65e25b25 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"65e25b25\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-13dcbfd9\" data-id=\"13dcbfd9\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3fb64446 elementor-widget elementor-widget-button\" data-id=\"3fb64446\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/2025\/04\/30131305\/informe-einf-neuraxpharm-pharmaceuticals-2023.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Nefinan\u010dn\u00ed report 2023<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-7a5f2b43 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7a5f2b43\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-335351dc\" data-id=\"335351dc\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-12297e51 elementor-widget elementor-widget-button\" data-id=\"12297e51\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/2025\/04\/30131248\/informe-einf-laboratorios-lesvi-2022.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Nefinan\u010dn\u00ed report 2022<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-4f0330e1 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4f0330e1\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-16dbec5\" data-id=\"16dbec5\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5ddd6ee0 elementor-widget elementor-widget-button\" data-id=\"5ddd6ee0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/2025\/04\/30131241\/informe-einf-laboratorios-lesvi-2021.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Nefinan\u010dn\u00ed report 2021<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Estado de Informaci\u00f3n No Financiera &#8211; EINF, ve \u0161pan\u011bl\u0161tin\u011b) Neuraxpharm Pharmaceuticals S.L.U. (d\u0159\u00edve Laboratorios Lesvi S.L.U.) p\u0159ipravuje ka\u017ed\u00fd rok v souladu se z\u00e1konem 11\/2018 t\u00fdkaj\u00edc\u00edm se nefinan\u010dn\u00edho reportingu a diverzity sv\u016fj nefinan\u010dn\u00ed reporting, kter\u00fd se \u0159\u00edd\u00ed doporu\u010den\u00edmi a \u00fadaji, je\u017e v\u00fd\u0161e zm\u00edn\u011bn\u00fd z\u00e1kon 11\/2018 stanovuje. Sou\u010d\u00e1st\u00ed tohoto reportu jsou informace t\u00fdkaj\u00edc\u00ed se \u017eivotn\u00edho prost\u0159ed\u00ed, soci\u00e1ln\u00edch [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-30944","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Nefinancni reporting - Neuraxpharm CZ<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/cz\/nefinancni-reporting\" \/>\n<meta property=\"og:locale\" content=\"cs_CZ\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nefinancni reporting\" \/>\n<meta property=\"og:description\" content=\"Estado de Informaci\u00f3n No Financiera &#8211; EINF, ve \u0161pan\u011bl\u0161tin\u011b) Neuraxpharm Pharmaceuticals S.L.U. (d\u0159\u00edve Laboratorios Lesvi S.L.U.) p\u0159ipravuje ka\u017ed\u00fd rok v souladu se z\u00e1konem 11\/2018 t\u00fdkaj\u00edc\u00edm se nefinan\u010dn\u00edho reportingu a diverzity sv\u016fj nefinan\u010dn\u00ed reporting, kter\u00fd se \u0159\u00edd\u00ed doporu\u010den\u00edmi a \u00fadaji, je\u017e v\u00fd\u0161e zm\u00edn\u011bn\u00fd z\u00e1kon 11\/2018 stanovuje. Sou\u010d\u00e1st\u00ed tohoto reportu jsou informace t\u00fdkaj\u00edc\u00ed se \u017eivotn\u00edho prost\u0159ed\u00ed, soci\u00e1ln\u00edch [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/cz\/nefinancni-reporting\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm CZ\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-07T08:52:56+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Odhadovan\u00e1 doba \u010dten\u00ed\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuta\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/cz\/nefinancni-reporting\",\"url\":\"https:\/\/www.neuraxpharm.com\/cz\/nefinancni-reporting\",\"name\":\"Nefinancni reporting - Neuraxpharm CZ\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/cz\/#website\"},\"datePublished\":\"2025-08-07T08:52:36+00:00\",\"dateModified\":\"2025-08-07T08:52:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/cz\/nefinancni-reporting#breadcrumb\"},\"inLanguage\":\"cs\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/cz\/nefinancni-reporting\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.neuraxpharm.com\/cz\/nefinancni-reporting#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.neuraxpharm.com\/cz\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nefinancni reporting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/cz\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/cz\/\",\"name\":\"Neuraxpharm CZ\",\"description\":\"Evropsk\u00fd l\u00eddr v oblasti produkt\u016f CNS\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/cz\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"cs\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Nefinancni reporting - Neuraxpharm CZ","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/cz\/nefinancni-reporting","og_locale":"cs_CZ","og_type":"article","og_title":"Nefinancni reporting","og_description":"Estado de Informaci\u00f3n No Financiera &#8211; EINF, ve \u0161pan\u011bl\u0161tin\u011b) Neuraxpharm Pharmaceuticals S.L.U. (d\u0159\u00edve Laboratorios Lesvi S.L.U.) p\u0159ipravuje ka\u017ed\u00fd rok v souladu se z\u00e1konem 11\/2018 t\u00fdkaj\u00edc\u00edm se nefinan\u010dn\u00edho reportingu a diverzity sv\u016fj nefinan\u010dn\u00ed reporting, kter\u00fd se \u0159\u00edd\u00ed doporu\u010den\u00edmi a \u00fadaji, je\u017e v\u00fd\u0161e zm\u00edn\u011bn\u00fd z\u00e1kon 11\/2018 stanovuje. Sou\u010d\u00e1st\u00ed tohoto reportu jsou informace t\u00fdkaj\u00edc\u00ed se \u017eivotn\u00edho prost\u0159ed\u00ed, soci\u00e1ln\u00edch [&hellip;]","og_url":"https:\/\/www.neuraxpharm.com\/cz\/nefinancni-reporting","og_site_name":"Neuraxpharm CZ","article_modified_time":"2025-08-07T08:52:56+00:00","twitter_card":"summary_large_image","twitter_misc":{"Odhadovan\u00e1 doba \u010dten\u00ed":"1 minuta"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/cz\/nefinancni-reporting","url":"https:\/\/www.neuraxpharm.com\/cz\/nefinancni-reporting","name":"Nefinancni reporting - Neuraxpharm CZ","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/cz\/#website"},"datePublished":"2025-08-07T08:52:36+00:00","dateModified":"2025-08-07T08:52:56+00:00","breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/cz\/nefinancni-reporting#breadcrumb"},"inLanguage":"cs","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/cz\/nefinancni-reporting"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/cz\/nefinancni-reporting#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.neuraxpharm.com\/cz\/"},{"@type":"ListItem","position":2,"name":"Nefinancni reporting"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/cz\/#website","url":"https:\/\/www.neuraxpharm.com\/cz\/","name":"Neuraxpharm CZ","description":"Evropsk\u00fd l\u00eddr v oblasti produkt\u016f CNS","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/cz\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"cs"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/pages\/30944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/comments?post=30944"}],"version-history":[{"count":7,"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/pages\/30944\/revisions"}],"predecessor-version":[{"id":30954,"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/pages\/30944\/revisions\/30954"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/media?parent=30944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}